Literature DB >> 11201248

Higher yielding isolation of kinsenoside in Anoectochilus and its antihyperliposis effect.

X Du1, N Sun, T Tamura, A Mohri, M Sugiura, T Yoshizawa, N Irino, J Hayashi, Y Shoyama.   

Abstract

A higher concentration of kinsenoside, 3-(R)-3-beta-D-glucopyranosyloxybutanolide (1), was detected in the crude drug Anoectochilusformosanus, and A. koshunensis by HPLC analysis. A methylation reaction occurred to give methyl ester (4) when the lactone ring of 1 was cleaved by silica gel catalysis using methanol containing solvent used in the purification step resulting in difficulty to purify 1. To avoid the cleavage reaction, a reversed-phase or silica gel column without methanol was used to give a high yield of 1. In an anti-hyperliposis assay using high-fat diet rats, 1 significantly reduced the weights of body and liver, and also decreased the triglyceride level in the liver compared to those of control rats. On the other hand, the epimer of 1, 3-(S)-3-beta-glucopyranosy-loxybutanolide (2), trivially named goodyeroside A, which was isolated from Goodyera species, had no effect for anti-hyperliposis. In aurothioglucose-induced obese mouse, 1 suppressed the body and liver weight increase, significantly ameliorated the triglyceride level in the liver, and also reduced the deposition of uterine fat-pads.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201248     DOI: 10.1248/bpb.24.65

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Promoting role of an endophyte on the growth and contents of kinsenosides and flavonoids of Anoectochilus formosanus Hayata, a rare and threatened medicinal Orchidaceae plant.

Authors:  Fu-sheng Zhang; Ya-li Lv; Yue Zhao; Shun-xing Guo
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

Review 2.  Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species.

Authors:  Chang-Xing Qi; Qun Zhou; Zhou Yuan; Zeng-Wei Luo; Chong Dai; Hu-Cheng Zhu; Chun-Mei Chen; Yong-Bo Xue; Jian-Ping Wang; Ya-Fen Wang; Ya-Ping Liu; Ming Xiang; Wei-Guang Sun; Jin-Wen Zhang; Yong-Hui Zhang
Journal:  Curr Med Sci       Date:  2018-03-15

3.  Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus.

Authors:  Phatcharaporn Budluang; Pornsiri Pitchakarn; Pisamai Ting; Piya Temviriyanukul; Ariyaphong Wongnoppawich; Arisa Imsumran
Journal:  Food Sci Nutr       Date:  2016-08-26       Impact factor: 2.863

4.  Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells.

Authors:  Qiao Han; Wang Bing; Yin Di; Li Hua; Li Shi-He; Zheng Yu-Hua; Han Xiu-Guo; Wang Yu-Gang; Fan Qi-Ming; Yang Shih-Mo; Tang Ting-Ting
Journal:  Cell Death Dis       Date:  2016-09-01       Impact factor: 8.469

5.  In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate.

Authors:  Shaheed Ur Rehman; Min Sun Choi; In Sook Kim; Zengwei Luo; Yongbo Xue; Guangming Yao; Yonghui Zhang; Hye Hyun Yoo
Journal:  Molecules       Date:  2016-06-18       Impact factor: 4.411

Review 6.  Vascular Epiphytic Medicinal Plants as Sources of Therapeutic Agents: Their Ethnopharmacological Uses, Chemical Composition, and Biological Activities.

Authors:  Ari Satia Nugraha; Bawon Triatmoko; Phurpa Wangchuk; Paul A Keller
Journal:  Biomolecules       Date:  2020-01-24

Review 7.  Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders.

Authors:  Li Lu; Yuan Xiong; Ze Lin; Xiangyu Chu; Adriana C Panayi; Yiqiang Hu; Juan Zhou; Bobin Mi; Guohui Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

8.  Kinsenoside Ameliorates Oxidative Stress-Induced RPE Cell Apoptosis and Inhibits Angiogenesis via Erk/p38/NF-κB/VEGF Signaling.

Authors:  Xu Luo; Shengjie Gu; Yujiao Zhang; Jianhong Zhang
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.